Shengshou Hu

1.6k total citations
67 papers, 1.1k citations indexed

About

Shengshou Hu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shengshou Hu has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 27 papers in Surgery and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shengshou Hu's work include Cardiac Valve Diseases and Treatments (11 papers), Cardiac Structural Anomalies and Repair (9 papers) and Congenital Heart Disease Studies (7 papers). Shengshou Hu is often cited by papers focused on Cardiac Valve Diseases and Treatments (11 papers), Cardiac Structural Anomalies and Repair (9 papers) and Congenital Heart Disease Studies (7 papers). Shengshou Hu collaborates with scholars based in China, United States and Netherlands. Shengshou Hu's co-authors include Hao Zhang, Liang Chen, Jiangping Song, Dongfeng Gu, Zhe Zheng, Paul Muntner, Paul K. Whelton, Jichun Chen, Anjali Gupta and Jiang He and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shengshou Hu

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengshou Hu China 20 499 291 254 150 129 67 1.1k
Donna R. Zwas Israel 24 1.0k 2.1× 327 1.1× 284 1.1× 230 1.5× 88 0.7× 91 1.8k
Hong Sang Choi South Korea 21 264 0.5× 203 0.7× 183 0.7× 172 1.1× 117 0.9× 118 1.3k
Ryan J. Koene United States 17 970 1.9× 271 0.9× 278 1.1× 142 0.9× 74 0.6× 36 1.7k
Jingfeng Wang China 20 451 0.9× 184 0.6× 382 1.5× 216 1.4× 167 1.3× 72 1.2k
Qiu‐Ting Dong China 22 542 1.1× 436 1.5× 227 0.9× 349 2.3× 402 3.1× 56 1.4k
Alice Bonomi Italy 22 710 1.4× 248 0.9× 134 0.5× 175 1.2× 152 1.2× 117 1.5k
Clinton D. Kemp United States 21 396 0.8× 639 2.2× 268 1.1× 206 1.4× 188 1.5× 33 1.7k
İbrahim Sarı Türkiye 22 390 0.8× 306 1.1× 164 0.6× 309 2.1× 222 1.7× 97 1.5k
Marcin Gruchała Poland 20 750 1.5× 492 1.7× 728 2.9× 113 0.8× 122 0.9× 153 2.0k
Yuli Huang China 21 490 1.0× 233 0.8× 1.0k 4.0× 166 1.1× 238 1.8× 67 2.0k

Countries citing papers authored by Shengshou Hu

Since Specialization
Citations

This map shows the geographic impact of Shengshou Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengshou Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengshou Hu more than expected).

Fields of papers citing papers by Shengshou Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengshou Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengshou Hu. The network helps show where Shengshou Hu may publish in the future.

Co-authorship network of co-authors of Shengshou Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengshou Hu. A scholar is included among the top collaborators of Shengshou Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengshou Hu. Shengshou Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Shen, Yu Han, Fangfang Wan, et al.. (2025). Targeting lysozyme 2 in endocardium promotes rapid recovery by modulating remote injury signals. Cell stem cell. 32(10). 1563–1576.e11. 1 indexed citations
3.
Hu, Shengshou. (2024). Epidemiology and current management of cerebrovascular disease in China. Journal of Geriatric Cardiology. 21(5). 465–474. 3 indexed citations
4.
Liu, Xuanyu, Kunlun Yin, Liang Chen, et al.. (2023). Lineage-specific regulatory changes in hypertrophic cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics. Cell Discovery. 9(1). 6–6. 37 indexed citations
5.
Wang, Shouzheng, Xu Meng, Shengshou Hu, et al.. (2022). Initial experiences of transapical beating‐heart mitral valve repair with a novel artificial chordal implantation device. Journal of Cardiac Surgery. 37(5). 1242–1249. 4 indexed citations
6.
Song, Jiangping, Liang Chen, Xiao Chen, et al.. (2020). Elevated plasma β-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy. Science Translational Medicine. 12(530). 64 indexed citations
7.
Rao, Man, Guangran Guo, Mengmeng Li, et al.. (2019). The homozygous variant c.245G > A/p.G82D in PNPLA2 is associated with arrhythmogenic cardiomyopathy phenotypic manifestations. Clinical Genetics. 96(6). 532–540. 8 indexed citations
8.
J, Ma, et al.. (2019). Efficacy and safety of olaparib maintenance therapy in platinum-sensitive ovarian cancer patients with BRCA mutations: a meta-analysis on randomized controlled trials. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Chen, Liang, Jiangping Song, & Shengshou Hu. (2018). Metabolic remodeling of substrate utilization during heart failure progression. Heart Failure Reviews. 24(1). 143–154. 40 indexed citations
10.
Ao, Hushan, Fei Xu, Xianqiang Wang, et al.. (2015). Effects of Metabolic Syndrome with or without Obesity on Outcomes after Coronary Artery Bypass Graft. A Cohort and 5-Year Study. PLoS ONE. 10(2). e0117671–e0117671. 10 indexed citations
11.
Hu, Shengshou. (2014). Current situation of heart transplantation:Chinese heart transplant annual report 2013. 35(6). 324–328. 3 indexed citations
12.
Song, Yunhu, et al.. (2013). Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. 29(1). 12–14. 3 indexed citations
13.
Li, Xuan, Bo Peng, Hongwei Guo, et al.. (2013). Modified Sakakibara classification system for ruptured sinus of Valsalva aneurysm. Journal of Thoracic and Cardiovascular Surgery. 146(4). 874–878. 25 indexed citations
14.
Wang, Shuiyun, Bin Cui, Hansong Sun, et al.. (2009). [Clinical experience of surgical treatment on hypertrophic obstructive cardiomyopathy].. PubMed. 89(39). 2776–8. 3 indexed citations
15.
Lin, Ye, Zhe Zheng, Yan Li, et al.. (2009). Impact of Renal Dysfunction on Long-Term Survival After Isolated Coronary Artery Bypass Surgery. The Annals of Thoracic Surgery. 87(4). 1079–1084. 20 indexed citations
16.
Hu, Shengshou. (2008). Fluid dynamics of a novel anti-calcification treated bioprosthetic heart valve. 1 indexed citations
17.
Zhang, Hao, Zhe Zheng, Jianye Zhou, et al.. (2007). Is It Possible to Obtain “True Endothelial Progenitor Cells” by In Vitro Culture of Bone Marrow Mononuclear Cells?. Stem Cells and Development. 16(4). 683–690. 29 indexed citations
18.
Ma, Wei‐Guo, et al.. (2006). Left Ventricular Rupture after Mitral Valve Replacement: A Report of 13 Cases. Asian Cardiovascular and Thoracic Annals. 14(1). 26–29. 10 indexed citations
19.
Hu, Shengshou. (2003). Surgical treatment for aortic regurgitation caused by aortitis. 2 indexed citations
20.
Tian, Guihua, et al.. (1998). [Effects of vestibular stimulus on heart rate variability].. PubMed. 11(6). 401–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026